Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1998
06/04/1998WO1998023290A1 Antipruritic agent
06/04/1998WO1998023282A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
06/04/1998WO1998023279A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
06/04/1998WO1998023278A1 Medicines for treating dementia or cognitive disorder, which comprises asiatic acid derivatives
06/04/1998WO1998023277A1 Use of mixtures of active substances, containing phytostenols and/or phytostenol esters and potentiators, for the production of hypocholesteremic agents
06/04/1998WO1998023275A1 Use of mixtures of active substances for the production of hypocholesteremic agents
06/04/1998WO1998023274A1 Androgenic and bisphosphonic agents coadministered to treat diseases
06/04/1998WO1998023273A1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
06/04/1998WO1998023272A1 Compositions and methods for the treatment of gastrointestinal disorders
06/04/1998WO1998023271A1 Composition containing diarylalkane derivative as the active ingredient for treating or preventing pancreatitis
06/04/1998WO1998023270A1 Pharmaceutical formulation
06/04/1998WO1998023269A1 Polythiophene anti-tumor agents
06/04/1998WO1998023268A1 Use of nitric oxide inhibitors for treating side effects of particulate drugs
06/04/1998WO1998023267A1 Use of hydroxyguanidines
06/04/1998WO1998023263A1 Ascending-dose dosage form
06/04/1998WO1998023260A2 Non-ionic surfactant vesicles as a delivery agent for nucleic acid
06/04/1998WO1998023257A1 Method for reducing skin oils and grease
06/04/1998WO1998023244A2 Intracoronary stents containing quinazolinone derivatives
06/04/1998WO1998023152A1 Stabilized ascorbyl compositions
06/04/1998WO1998017325A3 Covalent polar lipid conjugates for targeting
06/04/1998WO1998013493A3 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
06/04/1998WO1998010762A3 Controlled release dosage form of r-(z)-alpha-methoxyimino-alpha-(1-azabicyclo2.2oct-c-yl)acetonitrile monohydrochloride
06/04/1998WO1998009948A3 Nitric ester derivatives and their use in urinary incontinence and other diseases
06/04/1998WO1998009599A3 The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
06/04/1998WO1998003180A3 Use of sex steroids function modulators to treat wounds and fibrotic disorders
06/04/1998WO1998002149A3 Use of idebenone and analogues against beta amyloid induced cytotoxicity
06/04/1998DE19732323A1 Combination of vasodilator, microspheres and nitro-glycerine
06/04/1998DE19700796A1 Verwendung von Wirkstoffmischungen zur Herstellung von hypocholesterinämischen Mitteln Use of active compound mixtures for the production of hypocholesterolemic agents
06/04/1998DE19647692A1 Waschendes Desinfektionsmittel zur hygienischen und chirurgischen Händedesinfektion Washing disinfectants for hygienic and surgical hand disinfection
06/04/1998CA2273341A1 Use of mixtures of active substances, containing phytostenols and/or phytostenol esters and potentiators, for the production of hypocholesterolemic preparations
06/04/1998CA2273206A1 Lubricious self-standing (intact) gel for oral delivery of biologically-active ingredients
06/04/1998CA2273085A1 Composition containing diarylalkane derivative as the active ingredient for treating or preventing pancreatitis
06/04/1998CA2273021A1 Purification of fermented clavulanic acid
06/04/1998CA2272992A1 Synthetic glycoamines, methods for their use that affect cell
06/04/1998CA2272945A1 1,4-dihydropyridine derivatives
06/04/1998CA2272932A1 Use of hydroxyguanidines
06/04/1998CA2272916A1 Biaryl-pyridoquinazolinone derivatives as anti-cancer agents
06/04/1998CA2272915A1 Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer agents
06/04/1998CA2272900A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
06/04/1998CA2272754A1 Use of mixtures of active substances for the production of hypocholesterolemic agents
06/04/1998CA2272717A1 Cephalosporin derivatives
06/04/1998CA2272683A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998CA2272644A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998CA2272565A1 Integrin receptor antagonists
06/04/1998CA2272388A1 Benzamidoaldehydes and their use as cysteine protease inhibitors
06/04/1998CA2272275A1 Polythiophene anti-tumor agents
06/04/1998CA2272243A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
06/04/1998CA2271664A1 Androgenic and bisphosphonic agents coadministered to treat diseases
06/04/1998CA2270283A1 Human sqm1 protein homolog comprising a cell adhesion protein
06/04/1998CA2266605A1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
06/04/1998CA2243944A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit
06/04/1998CA2223541A1 New imidazoline derivatives, preparation process and the pharmaceutical compositions containing them
06/04/1998CA2223366A1 3-hydroxypyridine-2-carboxamidoesters, their preparation and their use as pharmaceuticals
06/03/1998EP0845539A1 Isolation and purification of tetrahydropyrimidine derivatives
06/03/1998EP0845535A2 Leader peptidase (lep) from Streptococcus
06/03/1998EP0845503A2 Liquid carotenoid compound preparations miscible with oil
06/03/1998EP0845476A2 Synthetic catalytic oligonucleotides
06/03/1998EP0845475A1 Inositolglycans with insular activity
06/03/1998EP0845467A1 Silicon containing sunscreen agents, and cosmetic sunscreen composition containing them
06/03/1998EP0845466A1 Silicon containing filtering agents and cosmetic sunscreen compositions containing them
06/03/1998EP0845464A2 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds as intermediates for camptothecin derivatives
06/03/1998EP0845271A1 Dressing material having a calcium alginate matrix and method of making the same
06/03/1998EP0845265A1 Mucosal preparation containing physiologically active peptide
06/03/1998EP0845263A1 Capsules containing diclofenac or salts thereof in solution
06/03/1998EP0845262A1 Effervescent propolis compositions
06/03/1998EP0845261A2 Sun protecting cosmetic compositions comprising derivatives of dibenzoylmethane, of benzophenone and of triazine
06/03/1998EP0845217A1 Inhibiting undesirable taste in oral compositions
06/03/1998EP0845216A1 A composition for administration to animals containing a tocopheryl phosphate
06/03/1998EP0845045A1 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors
06/03/1998EP0845036A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/03/1998EP0845034A1 Nucleic acid molecules encoding peptides having pronociceptive properties
06/03/1998EP0845007A2 Pharmaceutical composition containing inhibitors of interferon-gamma
06/03/1998EP0845005A1 Traf inhibitors
06/03/1998EP0845003A1 Novel opioid peptides
06/03/1998EP0845002A2 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
06/03/1998EP0845001A1 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents
06/03/1998EP0844999A1 Purification process
06/03/1998EP0844997A1 Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation
06/03/1998EP0844996A1 Substituted 1-indolylpropyl-4-phenethylpiperazine derivatives
06/03/1998EP0844891A1 Hyper comb-branched polymer conjugates
06/03/1998EP0844885A2 Chemical compounds
06/03/1998EP0844884A2 Endothelin antagonists and endothelin synthase inhibitors for the prevention and treatment of uterine contractility disorders, preeclampsia, atherosclerotic vascular disease, hypertension and for hormone replacement therapy
06/03/1998EP0844881A1 Combination osmotic and bulk forming laxatives
06/03/1998EP0844880A2 Contraceptive combined preparation, kits containing the same and contraceptive method using this combined preparation
06/03/1998EP0844879A1 Pharmaceutical compositions containing steroid derivatives involved in triggering an immune response
06/03/1998EP0844878A1 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis c
06/03/1998EP0844877A1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol
06/03/1998EP0844876A1 Endometrial ablation using photodynamic therapy with green porphyrins
06/03/1998EP0844875A2 Use of basic amino acids and derivatives for lowering ceramide levels
06/03/1998EP0844874A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF $g(a) v?$g(b) 5? MEDIATED ANGIOGENESIS
06/03/1998EP0844873A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same
06/03/1998EP0844869A1 Method and composition for treating asthma
06/03/1998EP0804209A4 Chemical castration
06/03/1998EP0734285B1 Deep-bed filter for exterminating micro-organisms and inactivating viruses and its use
06/03/1998EP0693073B1 Bicyclic ansamycins and their use as antitumor agents
06/03/1998EP0683767B1 Azacyclic compounds, compositions containing them and their use as tachykinin antagonists
06/03/1998CN1183811A Method for isolation and purification of lipid cell-wall components
06/03/1998CN1183781A Novel heterocyclic compounds
06/03/1998CN1183774A Trisubstd phenyl derivs
06/03/1998CN1183773A Alpha-substd. pyrimidine-thioalkyl and alkylether compounds
1 ... 6646 6647 6648 6649 6650 6651 6652 6653 6654 6655 6656 6657 6658 6659 6660 6661 6662 6663 6664 6665 6666 ... 7860